Relationship Between Oxidized LDL Antibodies and Different Stages of Esophageal Carcinoma

Archives of Medical Research

Volumn 39, Issue 8, 2008, Pages 760-767

  Wang, Yan ^a   Li, Hao ^b   Diao, Yutao ^c   Li, Huiqing ^c   Zhang, Yukun ^c   Yin, Chang ^c   Cui, Yongchun ^c   Ma, Qing ^c   Fang, Xueqiang ^a   Zhou, Yingzhi ^a   Yang, Yanfang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Antibodies against oxidized low density lipoproteins; Basal cell hyperplasia; Esophageal squamous cell carcinoma; Esophageal squamous cell dysplasia; Oxidative stress; Oxidized low density lipoproteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; IODINE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CELL HYPERPLASIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; SQUAMOUS CELL DYSPLASIA; SQUAMOUS EPITHELIUM; STAINING;

ADULT; AGED; AUTOANTIBODIES; CHINA; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 55249121704     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.08.002     Document Type: Article

References (69)

1. Dotan Y., Lichtenberg D., and Pinchuck I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43 (2004) 200-227
2. Saintot M., Astre C., Pujol H., and Gerber M. Tumor progression and oxidant-antioxidant status. Carcinogenesis 17 (1996) 1267-1271
3. Guyton K.Z., and Kensler T.W. Oxidative mechanisms in carcinogenesis. Br Med Bull 49 (1993) 523-544
4. Ray G., and Husain S.A. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34 (2001) 71-76
5. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashor S., et al. Lipid peroxidation, free radical, and antioxidant status in breast cancer. Breast Cancer Res Treat 59 (2000) 163-170
6. Nishi K., Itabe H., Uno M., Kitazato K.T., Horiguchi H., Shinno K., et al. Oxidized LDL in carotid plaques and plasma associated with plaque instability. Arterioscler Thromb Vasc Biol 22 (2002) 1649-1654
7. Esterbauer H., Gebicki J., Puhl H., and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13 (1992) 341-390
8. Mazière C., Meignotte A., Dantin F., Conte M.A., and Mazière J.C. Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem Biophys Res Commun 276 (2000) 718-723
9. Itabe H., Yamamoto H., Imanaka T., Shimamura K., Uchiyama H., Kimura J., et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 37 (1996) 45-53
10. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42 (2003) 318-343
11. Chung F.L., Nath R.G., Ocando J., Nishikawa A., and Zhang L. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res 60 (2000) 1507-1511
12. Sánchez-Pérez Y., Carrasco-Legleu C., García-Cuellar C., Pérez-Carreón J., Hernández-García S., Salcido-Neyoy M., et al. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett 217 (2005) 25-32
13. Sonoda I., Imoto I., Inoue J., Shibata T., Shimada Y., Chin K., et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64 (2004) 3741-3747
14. Yang Y.F., Li H., Xu X.Q., Diao Y.T., Fang X.F., Wang Y., et al. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. Dis Esophagus 21 (2008) 395-401
15. Li J.Y., Liu B.Q., Li G.Y., Chen Z.J., Sun X.I., and Rong S.D. Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research. Int J Epidemiol 10 (1981) 127-133
16. Jacob R.A., and Burri B.J. Oxidative damage and defense. Am J Clin Nutr 63 (1996) 985S-990S
17. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 Pt 1 (1996) 17-29
18. Galaris D., and Evangelou A. The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit Rev Oncol Hematol 42 (2002) 93-103
19. Regnstrom J., Nissson J., Toruvall P., Laudou C., and Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1183-1186
20. Brown N.S., and Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3 (2001) 323-327
21. Channon K.M. Oxidative stress and coronary plaque stability. Arterioscler Thromb Vasc Biol 22 (2002) 1751-1752
22. Delimaris I., Faviou E., Antonakos G., Stathopoulou E., Zachari A., and Dionyssiou-Asteriou A. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 40 (2007) 1129-1134
23. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 344 (1994) 721-724
24. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 2nd ed. (1989), Oxford University Press, Oxford, UK
25. Halliwell B., and Aruoma O.I. DNA and free radicals (1993), Ellis-Harwood, Chichester, UK
26. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
27. Malorni W., Straface E., Di Genova G., Fattorossi A., Rivabene R., Camponeschi B., et al. Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network. Exp Cell Res 236 (1997) 436-445
28. Steinberg D., Parthasarathy S., and Carew T.E. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
29. Holvoet P., Theilmeier G., Shivalkar B., Flameng W., and Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 18 (1998) 415-422
30. Shoji T., Nishizawa Y., Fukumoto M., Shimamura K., Kimura J., Kanda H., et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148 (2000) 171-177
31. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 95 (1997) 1062-1071
32. Salvayre R., Auge N., Benoist H., and Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585 (2002) 213-221
33. Li W., Yuan X.M., and Brunk U.T. OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic Res 29 (1998) 389-398
34. Rosenblat M., and Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Radic Biol Med 24 (1998) 305-317
35. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
36. Zettler M.E., Prociuk M.A., Austria J.A., Massaeli H., Zhong G., and Pierce G.N. OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol Heart Circ Physiol 284 (2003) H644-H653
37. Han C.Y., and Pak Y.K. Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp Mol Med 31 (1999) 165-173
38. Heichman K.A., and Roberts J.M. Rules to replicate by. Cell 79 (1994) 557-562
39. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
40. Motta M., Pistone G., Franzone A.M., Romeo M.A., Di Mauro S., Giugno I., et al. Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma. Panminerva Med 45 (2003) 69-73
41. Ullum H., Gøtzsche P.C., Victor J., Dickmeiss E., Skinhøj P., and Pedersen B.K. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 182 (1995) 789-799
42. Steinerová A., Racek J., Stozický F., Zima T., Fialová L., and Lapin A. Antibodies against oxidized LDL-theory and clinical use. Physiol Res 50 (2001) 131-141
43. Monaco C., Crea F., Niccoli G., Summaria F., Cianflone D., Bordone R., et al. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease: pathophysiological implications. Eur Heart J 22 (2001) 1572-1577
44. Yla-Herttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., and Witztum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14 (1994) 32-40
45. Suzuki K., Ito Y., Wakai K., Kawado M., Hashimoto S., Toyoshima H., et al. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol Biomarkers Prev 13 11 Pt 1 (2004) 1781-1787
46. Miller III E.R., Erlinger T.P., Blumenthal R.S., Margolis S., and Allen J.K. Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization. Coron Artery Dis 14 (2003) 163-169
47. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
48. Brändlein S., Rauschert N., Rasche L., Dreykluft A., Hensel F., Conzelmann E., et al. The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein. Mol Cancer Ther 6 (2007) 326-333
49. Pohle T., Brändlein S., Ruoff N., Müller-Hermelink H.K., and Vollmers H.P. Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation. Cancer Res 64 (2004) 3900-3906
50. Yasunobu Y., Hayashi K., Shingu T., Yamagata T., Kajiyama G., and Kambe M. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. Atherosclerosis 155 (2001) 445-453
51. Scott B., Liblau R., Degermann S., Marconi L.A., Ogata L., Caton A.J., et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1 (1994) 73-83
52. Zhang S., Hunter D.J., Forman M.R., Rosner B.A., Speizer F.E., Colditz G.A., et al. Dietary carotenoids, and vitamin A, C, E, and risk of breast cancer. J Natl Cancer Inst 91 (1999) 547-556
53. Holmes M.D., Hunter D.J., Colditz G.A., Stampfer M.J., Hankinson S.E., Speizer F.E., et al. Association of dietary intake of fat and fatty acids with risk of breast cancer. J Am Med Assoc 281 (1999) 914-920
54. Kakoglu E., Karaarslan Y., Karaasalan H.M., and Baloglu H. Alteration in serum lipids and lipoproteins in breast cancer. Cancer Lett 82 (1994) 175-178
55. Potischman N., McCulloch C.E., Byers T., Houghton L., Nemoto T., Graham S., et al. Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer 15 (1991) 205-215
56. Takatani O., Okumoto T., and Kosano H. Genesis of breast cancer in Japanese: a possible relationship between sex hormone-binding globulin (SHBG) and serum lipids components. Breast Cancer Res Treat 18 Suppl 1 (1991) S27-S29
57. Kumar K., Schdanandam R., and Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int 23 (1991) 581-589
58. Furberg A.S., Veierod M.B., Wilsgaard T., Bernstein L., and Thune I. Serum high-density lipoprotein cholesterol metabolic profile, and breast cancer risk. J Natl Cancer Inst 96 (2004) 1152-1160
59. Gadomska H., Janecki J., Marianowski L., and Nowicka G. Lipids in serum of patients with malignant ovarian neoplasms. Int J Gynecol Obstet 57 (1997) 287-293
60. Jiang J., Nilsson-Ehle P., and Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis 5 (2006) 4
61. Eggens I., Ekström T.J., and Aberg F. Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas. J Exp Pathol 71 (1990) 219-232
62. Siemianowicz K., Gminski J., Stajszczyk M., Wojakowski W., Goss M., Machalski M., et al. Serum total cholesterol and triglyceride levels in patients with lung cancer. Int J Mol Med 5 (2000) 201-205
63. Siemianowicz K., Gminski J., Stajszczyk M., Wojakowski W., Goss M., Machalski M., et al. Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. Int J Mol Med 6 (2000) 307-311
64. Dessi S., Batetta B., Pulisci D., Spano O., Anchisi C., Tessitore L., et al. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73 (1994) 253-258
65. Barcley M., Skipski V.P., Terebus-Kekish O., Greene E.M., Kaufman R.J., and Stock C.C. Effects of cancer upon high density and other lipoproteins. Cancer Res 30 (1970) 2420-2430
66. Simó Camps E., Ortí Llavería A., Sena Ferrer F., and Contreras Barbeta E. Blood cholesterol in patients with cancer. Ann Intern Med 15 (1998) 363-366
67. Michiel D.F., and Oppenheim J.J. Cytokines as positive and negative regulators of tumor promotion and progression. Semin Cancer Biol 3 (1992) 3-15
68. Cheung D.L., Hart P.H., Vitti G.F., Whitty G.A., and Hamilton J.A. Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 71 (1990) 70-75
69. Larking P.W. Cancer and low levels of plasma cholesterol: the relevance of cholesterol precursors and products to incidence of cancer. Prev Med 29 (1999) 383-390